Where These Numbers Come From Tesamorelin's dosing rationale comes from the HIV lipodystrophy trials (Falutz et al., 2007
Drop to 1,400 calories, which is common on GLP-1 medications, and hitting that same target becomes nearly impossible without supplementation
However, to date, there is only one randomized clinical trial of GLP-1 RAs (the ELIXA study) evaluating major cardiovascular events as their primary outcomes, and in this study, a neutral cardiovascular effect of lixisenatide was observed in high-risk diabetic subjects
We do not recommend combining intermittent fasting with GLP medication
Omega-3 fatty acids are associated with improved lipid profiles and reduced inflammatory markers, while too many omega-6 fatty acids, relative to omega-3s, may lead to adverse effects on lipid profiles and an increase in inflammation
It is a part of voluntary service provided by the American Society for Clinical Laboratory Science.